GlassScriptPhysician profile
Irwin Robert Dudow
NPI 1942277678
$1,399.91
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $914 · 2020: $10.45 · 2021: $255 · 2022: $130 · 2023: $90.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $90.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $90.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $570.90 | 2019-2021 | |
| Maculogix, INC. | $168.34 | 2019 | |
| Bausch & Lomb Americas INC. | $129.84 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2021 | |
| Regeneron Pharmaceuticals, INC. | $110.18 | 2019 | |
| Apellis Pharmaceuticals, INC. | $90.38 | 2023 | |
| Novartis Pharmaceuticals Corporation | $75.39 | 2019 | |
| Carl Zeiss Meditec, INC. | $60.36 | 2019 | |
| Genentech USA, INC. | $59.07 | 2019 | |
| Optos, INC. | $10.45 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irwin Dudow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.